CHI appoints Principal Scientist

CHI appoints Principal Scientist

Cambridge, UK – 30 November 2021: Cambridge Healthcare Innovations Ltd (CHI), a medical device development company, is pleased to announce the appointment of Jamie Greenwood as Principal Scientist. At CHI Jamie will lead the technology testing programmes, as well as managing the CHI laboratory.

Jamie has over 19 years of experience in medical and consumer product development and testing, having been Head of Device Testing at the medical device design consultancy Team Consulting (Cambridge), before which he was a Senior Scientist at Cambridge Consultants.

Jamie has developed deep expertise in test requirements and best practices for a range of medical products, both leading and conducting test programmes across the entire development cycle from Proof of Concept through to formal Device Verification Testing (DVeT). Jamie has supported development, testing, and regulatory submissions for dozens of medical products, including surgical instruments, diagnostic systems, needle injection systems, and aerosol drug delivery devices.

Jamie’s experience and skillset in aerosol testing and best practices will be put to immediate use on CHI’s platform dry powder inhaler (DPI) technology, αeolus, which is being developed and commercialised in collaboration with the leading contract development and manufacturing organisation Kindeva Drug Delivery.

Philip Canner, CEO, commented:

“We are delighted to welcome Jamie to the CHI team. Jamie’s skillset and approach is an ideal fit for CHI as we develop αeolus and further the capabilities of the company. His deep expertise and knowledge of best practice in medical device testing, and of pulmonary drug delivery devices in particular, takes CHI’s in-house testing capabilities to the next level.”

Jamie Greenwood, Principal Scientist, commented:

“I’m really excited to have joined the talented team at CHI. The αeolus technology has so much potential, and I can’t wait to get stuck in and put my product development experience and testing skills to best use to help CHI and our collaboration partner, Kindeva, take this technology to market.”

About Cambridge Healthcare Innovations

Cambridge Healthcare Innovations Ltd. is focused on improving the wellbeing and quality of life of patients through the development and implementation of innovative technologies. Founded in August 2018, CHI has patented two technologies to improve the delivery of respiratory medicine – “q‑technology” and “αeolus”.